Berubicin
- Generic Name
- Berubicin
- Drug Type
- Small Molecule
- Chemical Formula
- C34H35NO11
- CAS Number
- 677017-23-1
- Unique Ingredient Identifier
- 6QPN83HK2M
A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- WPD Pharmaceuticals Sp. z o.o.
- Registration Number
- NCT05082493
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
- Conditions
- Recurrent Glioblastoma Multiforme
- Interventions
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- WPD Pharmaceuticals Sp. z o.o.
- Target Recruit Count
- 5
- Registration Number
- NCT04915404
- Locations
- 🇵🇱
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii, Gdańsk, Poland
🇵🇱Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie,Państwowy Instytut Badawczy w Warszawie,Klinika Nowotworów Głowy i Szyi, Warszawa, Poland
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
- Conditions
- Glioblastoma Multiforme, Adult
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- CNS Pharmaceuticals, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT04762069
- Locations
- 🇺🇸
Baylor Research Institute, Dallas, Texas, United States
🇺🇸Southern California Permanente Medical Group, Los Angeles, California, United States
🇺🇸Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Reata, a wholly owned subsidiary of Biogen
- Target Recruit Count
- 14
- Registration Number
- NCT00538343
- Locations
- 🇺🇸
Forsyth Regional Cancer Center, Winston-Salem, North Carolina, United States
🇺🇸Presbyterian Health Care, Charlotte, North Carolina, United States
🇺🇸Virginia Oncology Associates, Newport News, Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.